Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 23

Trial Status

Completed3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00477750Phase 1/2Completed
Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Multiple Myeloma and Plasma Cell Neoplasm
Principalinvestigator
NCT00564889Phase 2Completed
Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis
Multiple Myeloma and Plasma Cell Neoplasm
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Mayo Clinic

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

George Somlo, MD

City of Hope Medical Center

Moderately Similar
10 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Debra Barton, RN, PhD, AOCN, FAAN

Mayo Clinic

Moderately Similar
7 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Jeffrey J. Raizer, MD

Robert H. Lurie Cancer Center

Moderately Similar
6 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Claudio G. Brunstein, MD, PhD

Masonic Cancer Center, University of Minnesota

Moderately Similar
7 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Moderately Similar
24 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Mohamad A. Hussein, MD

The Cleveland Clinic

Moderately Similar
8 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

William I. Bensinger, MD

Fred Hutchinson Cancer Center

Moderately Similar
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Thomas E. Witzig, MD

Mayo Clinic

Moderately Similar
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Charles L. Loprinzi, MD

Mayo Clinic

Moderately Similar
14 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score30%

Jeffrey S. Weber, MD, PhD

University of Southern California

Moderately Similar
9 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00477750Phase 1/2PrincipalInvestigator

Melphalan, Prednisone, and Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00478218Phase 2PrincipalInvestigator

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Completed
NCT00564889Phase 2PrincipalInvestigator

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Multiple Myeloma and Plasma Cell Neoplasm
Completed

All 3 trials loaded